Titles
- Assessing user fees under the biosimilar user fee amendments of 20171
- Assessment and synthesis of selected Medicaid eligibility, enrollment, and renewal processes and systems in six states1
- Association between electronic medical record implementation of default opioid prescription quantities and prescribing behavior in two emergency departments1
- Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents1
- Association of rideshare-based transportation services and missed primary care appointments: a clinical trial1
- BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment1
- Behavioral health integration and workforce development1
- Best practices for reducing unplanned acute care for patients with cancer1
- Beyond health care: the role of social determinants in promoting health and health equity1
- Bioanalytical method validation1
- Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report1
- Brand name prescription drug prices increase four times faster than inflation in 20171
- Breaking barriers for underrepresented minorities in the health professions1
- Breaking new ground: supporting employed family caregivers with workplace leave policies1
- Breaking through the noise: the facts about the Medicaid program1
- Breast cancer treatment and continuity of care in California: policy solutions to help patients maintain consistent care1
- Building healthy communities: one funder's place-based approach to help neighborhoods transform themselves1
- CBO's long-term Social Security projections: changes since 2017 and comparisons with the Social Security trustees' projections1
- CMS Innovation Center: model implementation and center performance : report to Congressional requesters1
- CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities1